Last reviewed · How we verify
Placebo groups
Placebo groups serve as control arms in clinical trials to establish baseline disease progression and distinguish true drug effects from natural history and observer bias.
At a glance
| Generic name | Placebo groups |
|---|---|
| Sponsor | National Institute of Pediatrics, Mexico |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebo groups receive inactive treatment and allow researchers to measure the natural course of disease, spontaneous remission rates, and placebo response effects. By comparing active drug outcomes to placebo outcomes, investigators can isolate the true pharmacological benefit of the investigational agent. This is a methodological control rather than a therapeutic intervention.
Approved indications
Common side effects
Key clinical trials
- A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP) (PHASE2)
- The Effect of NP-2006 on Sleep Quality and Health (NA)
- A Clinical Trial Evaluating the Monkeypox Recombinant Protein Vaccine (PHASE1)
- Effects of Percutaneous Electrical Stimulation in Patients With Chronic Supraspinatus Tendinopathy (NA)
- Project Tendura: The Impact of Blood Flow Restriction Resistance Training (BFR-RT) in Patients With Achilles Tendon Rupture (ATR) Repair (NA)
- Effect of Kinesio Taping Application in Addition to Pilates Exercises on Core Muscle Thickness, Cognition and Mental Fatigue in Individuals With Non-specific Low Back Pain (NA)
- Nutritional Effects in Cardiovascular Surgery (NA)
- The RECLAIM Study. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |